Register Here - Free for Members and non-Members

Following decades of work by many clinicians and researchers it has been difficult to quantify the neurodevelopmental benefits of DHA supplementation in the neonatal period for very preterm children.  Our presentation will focus on two long term trials, the DINO and N3RO trials, conducted over the last 20 years and involving almost 2,000 very preterm children, showing the importance of meeting the in-utero DHA requirements in early life for later cognitive outcomes and discuss the influence of DHA on other disease of prematurity. 

 Webinars are typically posted within 24 hours of completion.
Presentations will be available for 30 days and then moved to the ISSFAL Members Only section of the website.